Evaluating results from the multiple myeloma patient subset treated with denosumab or zoledronic acid in a randomized phase 3 trial

por Raje, N, Vadhan-Raj, S, Willenbacher, W, Terpos, E, Hungria, V, Spencer, A, Alexeeva, Y, Facon, T, Stewart, A K, Feng, A, Braun, A, Balakumaran, A, Roodman, G D
Publicado 2016

P925: IMPACT OF PRIOR TREATMENT EXPOSURE ON THE EFFECTIVENESS OF IXAZOMIB-LENALIDOMIDE-DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS TREATED IN ROUTINE CLINICAL PR...

por Lee, H. C., Ramasamy, K., Macro, M., Davies, F. E., Abonour, R., van Rhee, F., Hungria, V. T., Puig, N., Ren, K., Silar, J., Enwemadu, V., Cherepanov, D., Stull, D. M., Leleu, X.
Publicado 2022

P04: DARATUMUMAB PLUS BORTEZOMIB AND DEXAMETHASONE VERSUS BORTEZOMIB AND DEXAMETHASONE ALONE IN PATIENTS WITH PREVIOUSLY TREATED MULTIPLE MYELOMA: OVERALL SURVIVAL RESULTS FROM THE...

por Sonneveld, P, Chanan-Khan, A, Weisel, K, Nooka, AK, Masszi, T, Beksac, M, Spicka, I, Hungria, V, Munder, M, Mateos, MV, Mark, TM, Levin, MD, Ahmadi, T, Qin, X, Garvin Mayo, W, Gai, X, Carey, J, Carson, R, Spencer, A
Publicado 2022

PB1993: MULTIPLE MYELOMA BRAZILIAN REGISTER- HOW ABOUT THE TRANSPLANT ELIGIBLE PATIENTS?

por Crusoe, E., Ribeiro, G., Zanella, K., Perobelli, L., Saraiva FIlho, J. C., Magalhaes, R., Bittencourt, R., Souza, E., Centrone, R., Hamerschlak, N., Gaiolla, R., Gusmao, B., HIgashi, F., Farley, J., Capra, M., Braga, W., Hallack Neto, A., Vaz P Neto, J., Bonamin, C., Silva, C., Souto Filho, J. T., Martinez, G., Mattos, E., Castro, N., da Silva, L., Farnese, V., Tavares, R., Bigonha, J., Lima, J., Ribeiro, E., Cunha, R., Nucci, F., Almeida, M., Cruz, L., Maiolino, A., Hungria, V.
Publicado 2022